Investor Relations
Firefly Neuroscience is now a non-exclusive distributor for Zeto’s pair of EEG-headsets, called WR19 and Zeto ONE.
Zeto has formed a partnership with Firefly Neuroscience that boosts the distribution of Zeto’s FDA-cleared EEG headset devices.
Canada's Firefly Neuroscience has completed a listing on the Nasdaq via a $45 million reverse merger with IT group WaveDancer, opening up new financing routes for its artificial intelligence-powered platform for measuring brain function.
Roche announced the completion of the acquisition of LumiraDx’s Point of Care technology.
Firefly Neuroscience, Inc., an AI technology company developing innovative neuroscientific solutions that improve brain health outcomes for patients with mental illnesses and neurological disorders, announced that it has formed a strategic partnership with the Neurology Consultants of Dallas to help enhance early detection efforts and disease management for patients suffering from cognitive decline.
© 2024 Firefly Neuroscience, Inc. Powered by Issuer Direct.